Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$684M |
| 2 |
Amgen
AMGN
|
+$653M |
| 3 |
Salesforce
CRM
|
+$488M |
| 4 |
Eli Lilly
LLY
|
+$452M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$437M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$815M |
| 2 |
NVIDIA
NVDA
|
+$685M |
| 3 |
TJX Companies
TJX
|
+$488M |
| 4 |
Starbucks
SBUX
|
+$373M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.92% |
| 2 | Healthcare | 18.9% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 9.11% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Crinetics Pharmaceuticals
CRNX
$8.87B
| $110M | 0.06% |
2,455,661
+477,489
| +24% | +$22.1M |
|
252
BridgeBio Pharma
BBIO
$16.5B
| $109M | 0.06% |
4,312,531
+999,825
| +30% | +$27.3M |
|
253
Shift4
FOUR
$3.96B
| $107M | 0.06% |
1,454,714
+19,824
| +1% | +$1.31M |
|
|
ETNB
254
DELISTED
89bio
ETNB
| $106M | 0.06% |
13,276,110
+672,728
| +5% | +$6.01M |
|
255
Regeneron Pharmaceuticals
REGN
$69.9B
| $106M | 0.06% |
100,424
-3,568
| -3% | -$3.46M |
|
|
ACLX
256
DELISTED
Arcellx
ACLX
| $105M | 0.06% |
1,902,618
+380,309
| +25% | +$20.7M |
|
|
ALTR
257
DELISTED
Altair Engineering Inc
ALTR
| $105M | 0.06% |
1,068,822
+831
| +0.1% | +$73.1K |
|
258
Legend Biotech
LEGN
$3.73B
| $104M | 0.06% |
2,359,056
+345,044
| +17% | +$15.9M |
|
259
Surgery Partners
SGRY
$1.98B
| $103M | 0.05% |
4,312,918
+1,808,670
| +72% | +$46.4M |
|
260
Gates Industrial Corporation Ltd.
GTES
$6.72B
| $102M | 0.05% |
6,477,036
+12,286
| +0.2% | +$208K |
|
|
SUM
261
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $101M | 0.05% |
2,769,306
-73,419
| -3% | -$2.88M |
|
262
BellRing Brands
BRBR
$1.52B
| $101M | 0.05% |
1,768,608
-189,072
| -10% | -$10.8M |
|
263
Telus
TU
$16.2B
| $101M | 0.05% |
6,652,731
+2,080,699
| +46% | +$33.5M |
|
264
Maximus
MMS
$3.2B
| $99.6M | 0.05% |
1,162,439
-92,097
| -7% | -$7.74M |
|
265
Donaldson
DCI
$10.8B
| $99.4M | 0.05% |
1,388,500
-644
| -0% | -$47.3K |
|
266
UL Solutions
ULS
$18.2B
| $98.2M | 0.05% |
+2,328,210
| New | +$88.1M |
|
267
Cisco
CSCO
$452B
| $97.7M | 0.05% |
2,056,523
-66,617
| -3% | -$3.16M |
|
268
Agree Realty
ADC
$9.66B
| $96.4M | 0.05% |
1,556,436
+7,373
| +0.5% | +$436K |
|
269
Aptiv
APTV
$12.2B
| $96.2M | 0.05% |
1,366,240
-616,229
| -31% | -$47.4M |
|
270
Wynn Resorts
WYNN
$10.3B
| $95.6M | 0.05% |
1,068,586
-57,132
| -5% | -$5.48M |
|
271
HealthEquity
HQY
$8.28B
| $94.9M | 0.05% |
1,101,473
+758
| +0.1% | +$61.2K |
|
272
Advanced Drainage Systems
WMS
$11B
| $94.3M | 0.05% |
588,187
+14,970
| +3% | +$2.5M |
|
273
Saia
SAIA
$11.2B
| $93.6M | 0.05% |
197,301
-21,036
| -10% | -$9.8M |
|
274
Mirion Technologies
MIR
$4.12B
| $93.3M | 0.05% |
8,685,267
-717,847
| -8% | -$7.63M |
|
275
Kirby Corp
KEX
$7.76B
| $93.2M | 0.05% |
778,149
-177,438
| -19% | -$19.8M |
|
Similar funds
Janus Henderson Group's Q2 2024 Portfolio in Review
As of Q2 2024, Janus Henderson Group held 2,619 positions worth $187B, up 1.9% from $183B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q2 2024 filing shows 91 new, 630 increased, 1,758 reduced and 101 closed positions. Its largest new stake was UL Solutions: 2,328,210 shares worth $98.2M. The largest sale was Adobe, an estimated $815M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2024 buy was UL Solutions: 2,328,210 shares worth $98.2M.
- Janus Henderson Group added most to Broadcom in Q2 2024, an estimated $684M increase.
- Janus Henderson Group's biggest Q2 2024 reduction was Adobe, cutting an estimated $815M.
- Janus Henderson Group fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $157M.
- Janus Henderson Group's ten largest holdings make up 32% of its $187B portfolio in Q2 2024.
- Janus Henderson Group opened 91 new positions and closed 101 in Q2 2024.
- Janus Henderson Group's portfolio value rose 1.9% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.